论文信息 - Acute efficacy of combined therapy of carperitide and nicorandil for acute decompensated heart failure with left ventricular systolic dysfunction. - 字舞流文

Acute efficacy of combined therapy of carperitide and nicorandil for acute decompensated heart failure with left ventricular systolic dysfunction.

K. Kajimoto | K. Shimamura

[1] K. Kajimoto,et al. Acute efficacy of low-dose human atrial natriuretic peptide monotherapy without loop diuretics for acute decompensated heart failure with left ventricular systolic dysfunction: a case report. , 2010, International journal of cardiology.

[2] A. Coats,et al. Ethical authorship and publishing. , 2009, International journal of cardiology.

[3] G. Felker,et al. Vasodilators in the treatment of acute heart failure: what we know, what we don’t , 2008, Heart Failure Reviews.

[4] Y. Okutani,et al. Multicenter prospective investigation on efficacy and safety of carperitide as a first-line drug for acute heart failure syndrome with preserved blood pressure: COMPASS: Carperitide Effects Observed Through Monitoring Dyspnea in Acute Decompensated Heart Failure Study. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[5] A. Parkhomenko,et al. Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes. , 2008, Critical care medicine.

[6] K. Dickstein,et al. Comparison of the degree of hemodynamic tolerance during intravenous infusion of nitroglycerin versus nicorandil in patients with congestive heart failure. , 1997, American heart journal.